Palatin Technologies, Inc. (PTN)
USD 0.75
(-9.64%)
USD 0.75
(-9.64%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 4.49 Million USD | -7.49% |
| 2023 | 4.85 Million USD | 230.53% |
| 2022 | 1.46 Million USD | 878.62% |
| 2021 | -188.59 Thousand USD | -259.84% |
| 2020 | 117.98 Thousand USD | -99.8% |
| 2019 | 60.3 Million USD | -10.18% |
| 2018 | 67.13 Million USD | 50.11% |
| 2017 | 44.72 Million USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 12.95 Million USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 10.36 Thousand USD | -85.95% |
| 2012 | 73.73 Thousand USD | -95.0% |
| 2011 | 1.47 Million USD | -89.6% |
| 2010 | 14.18 Million USD | 24.92% |
| 2009 | 11.35 Million USD | -1.15% |
| 2008 | 11.48 Million USD | -20.29% |
| 2007 | 14.4 Million USD | -27.05% |
| 2006 | 19.74 Million USD | 9.98% |
| 2005 | 17.95 Million USD | 675.64% |
| 2004 | 2.31 Million USD | 82.29% |
| 2003 | 1.27 Million USD | 351.39% |
| 2002 | 281.35 Thousand USD | -84.27% |
| 2001 | 1.78 Million USD | -65.06% |
| 2000 | 5.11 Million USD | 752.85% |
| 1999 | 600 Thousand USD | 500.0% |
| 1998 | 100 Thousand USD | -85.71% |
| 1997 | 700 Thousand USD | 3400.0% |
| 1996 | 20 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.1 Million USD | 19.53% |
| 2024 Q4 | 350 Thousand USD | 0.0% |
| 2024 Q3 | - USD | -100.0% |
| 2024 Q2 | 2.03 Million USD | -3.41% |
| 2023 FY | 4.85 Million USD | 230.53% |
| 2023 Q3 | 1.19 Million USD | 16.49% |
| 2023 Q2 | 1.02 Million USD | 18.03% |
| 2023 Q1 | 869.65 Thousand USD | 12.83% |
| 2023 Q4 | 1.76 Million USD | 47.36% |
| 2022 FY | 1.46 Million USD | 878.62% |
| 2022 Q1 | 159.48 Thousand USD | -8.97% |
| 2022 Q2 | 322.14 Thousand USD | 101.99% |
| 2022 Q3 | 216.09 Thousand USD | -32.92% |
| 2022 Q4 | 770.73 Thousand USD | 256.66% |
| 2021 Q1 | -288.56 Thousand USD | -33.98% |
| 2021 FY | -188.59 Thousand USD | -259.84% |
| 2021 Q2 | -163.97 Thousand USD | 43.18% |
| 2021 Q3 | 88.74 Thousand USD | 154.12% |
| 2021 Q4 | 175.19 Thousand USD | 97.42% |
| 2020 Q3 | 97.37 Thousand USD | 372.48% |
| 2020 Q1 | 97.37 Thousand USD | -99.84% |
| 2020 Q2 | 20.61 Thousand USD | -78.84% |
| 2020 Q4 | -215.36 Thousand USD | -321.16% |
| 2020 FY | 117.98 Thousand USD | -99.8% |
| 2019 Q2 | - USD | -100.0% |
| 2019 Q1 | 34.5 Thousand USD | -99.83% |
| 2019 Q3 | 34.5 Thousand USD | 0.0% |
| 2019 Q4 | 60.26 Million USD | 174558.66% |
| 2019 FY | 60.3 Million USD | -10.18% |
| 2018 Q2 | 10.61 Million USD | -60.61% |
| 2018 Q1 | 26.94 Million USD | -20.53% |
| 2018 FY | 67.13 Million USD | 50.11% |
| 2018 Q3 | 8.96 Million USD | -15.54% |
| 2018 Q4 | 20.61 Million USD | 130.05% |
| 2017 Q3 | 10.82 Million USD | 0.0% |
| 2017 Q4 | 33.9 Million USD | 213.2% |
| 2017 FY | 44.72 Million USD | 0.0% |
| 2017 Q2 | - USD | -100.0% |
| 2017 Q1 | 10.82 Million USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | -100.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 100.0% |
| 2015 Q4 | -17.88 Million USD | -462.59% |
| 2015 Q2 | 8.01 Million USD | 62.59% |
| 2015 FY | 12.95 Million USD | 0.0% |
| 2015 Q3 | 4.93 Million USD | -38.5% |
| 2015 Q1 | 4.93 Million USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 100.0% |
| 2014 FY | - USD | -100.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q3 | 3806.00 USD | -41.94% |
| 2013 Q4 | -14.16 Thousand USD | -472.23% |
| 2013 FY | 10.36 Thousand USD | -85.95% |
| 2013 Q1 | 3806.00 USD | -65.5% |
| 2013 Q2 | 6555.00 USD | 72.23% |
| 2012 FY | 73.73 Thousand USD | -95.0% |
| 2012 Q4 | 11.03 Thousand USD | -54.03% |
| 2012 Q3 | 23.99 Thousand USD | 108.81% |
| 2012 Q2 | 11.49 Thousand USD | -57.78% |
| 2012 Q1 | 27.21 Thousand USD | -82.54% |
| 2011 FY | 1.47 Million USD | -89.6% |
| 2011 Q4 | 155.84 Thousand USD | 154.25% |
| 2011 Q3 | 61.29 Thousand USD | -94.12% |
| 2011 Q2 | 1.04 Million USD | 382.16% |
| 2011 Q1 | 216.14 Thousand USD | -67.98% |
| 2010 Q4 | 674.95 Thousand USD | -73.63% |
| 2010 Q2 | 7.28 Million USD | 98.85% |
| 2010 Q1 | 3.66 Million USD | -13.35% |
| 2010 FY | 14.18 Million USD | 24.92% |
| 2010 Q3 | 2.55 Million USD | -64.85% |
| 2009 FY | 11.35 Million USD | -1.15% |
| 2009 Q2 | 1.21 Million USD | 60.7% |
| 2009 Q3 | 5.15 Million USD | 325.91% |
| 2009 Q4 | 4.22 Million USD | -18.07% |
| 2009 Q1 | 753.84 Thousand USD | -25.79% |
| 2008 FY | 11.48 Million USD | -20.29% |
| 2008 Q1 | 8.97 Million USD | 240.4% |
| 2008 Q2 | 742.83 Thousand USD | -91.73% |
| 2008 Q3 | 746.95 Thousand USD | 0.55% |
| 2008 Q4 | 1.01 Million USD | 35.99% |
| 2007 Q1 | 4.93 Million USD | -0.76% |
| 2007 FY | 14.4 Million USD | -27.05% |
| 2007 Q3 | 3.09 Million USD | -17.45% |
| 2007 Q2 | 3.74 Million USD | -24.15% |
| 2007 Q4 | 2.63 Million USD | -14.65% |
| 2006 FY | 19.74 Million USD | 9.98% |
| 2006 Q2 | 4.58 Million USD | -10.82% |
| 2006 Q4 | 4.97 Million USD | -1.43% |
| 2006 Q3 | 5.04 Million USD | 9.98% |
| 2006 Q1 | 5.14 Million USD | -12.0% |
| 2005 Q1 | 4.49 Million USD | 43343.46% |
| 2005 Q2 | 4.81 Million USD | 7.17% |
| 2005 Q3 | 2.8 Million USD | -41.69% |
| 2005 FY | 17.95 Million USD | 675.64% |
| 2005 Q4 | 5.84 Million USD | 108.24% |
| 2004 FY | 2.31 Million USD | 82.29% |
| 2004 Q2 | 291.35 Thousand USD | -84.1% |
| 2004 Q3 | 180.75 Thousand USD | -37.96% |
| 2004 Q4 | 10.33 Thousand USD | -94.28% |
| 2004 Q1 | 1.83 Million USD | 2115.8% |
| 2003 Q2 | 233.5 Thousand USD | -62.55% |
| 2003 Q4 | 82.71 Thousand USD | -74.96% |
| 2003 Q3 | 330.29 Thousand USD | 41.45% |
| 2003 Q1 | 623.5 Thousand USD | 532.47% |
| 2003 FY | 1.27 Million USD | 351.39% |
| 2002 Q3 | 99.43 Thousand USD | 138.65% |
| 2002 FY | 281.35 Thousand USD | -84.27% |
| 2002 Q1 | 41.66 Thousand USD | -75.0% |
| 2002 Q2 | 41.66 Thousand USD | 0.0% |
| 2002 Q4 | 98.58 Thousand USD | -0.86% |
| 2001 FY | 1.78 Million USD | -65.06% |
| 2001 Q4 | 166.66 Thousand USD | 64.12% |
| 2001 Q3 | 101.55 Thousand USD | -84.72% |
| 2001 Q2 | 664.79 Thousand USD | -22.25% |
| 2001 Q1 | 855.08 Thousand USD | -8.0% |
| 2000 Q4 | 929.42 Thousand USD | -34.92% |
| 2000 Q2 | 1 Million USD | -44.44% |
| 2000 Q3 | 1.42 Million USD | 42.81% |
| 2000 Q1 | 1.8 Million USD | 12.5% |
| 2000 FY | 5.11 Million USD | 752.85% |
| 1999 Q4 | 1.6 Million USD | 1500.0% |
| 1999 Q1 | 100 Thousand USD | -93.75% |
| 1999 Q2 | 600 Thousand USD | 500.0% |
| 1999 FY | 600 Thousand USD | 500.0% |
| 1999 Q3 | 100 Thousand USD | -83.33% |
| 1998 Q1 | 100 Thousand USD | 25.0% |
| 1998 FY | 100 Thousand USD | -85.71% |
| 1998 Q4 | 1.6 Million USD | 1500.0% |
| 1998 Q2 | 100 Thousand USD | 0.0% |
| 1998 Q3 | 100 Thousand USD | 0.0% |
| 1997 Q4 | 80 Thousand USD | -87.1% |
| 1997 Q1 | 20 Thousand USD | 0.0% |
| 1997 FY | 700 Thousand USD | 3400.0% |
| 1997 Q3 | 620 Thousand USD | 0.0% |
| 1997 Q2 | - USD | -100.0% |
| 1996 FY | 20 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AIM ImmunoTech Inc. | 202 Thousand USD | -2122.817% |
| Ampio Pharmaceuticals, Inc. | - USD | -Infinity% |
| Armata Pharmaceuticals, Inc. | 4.52 Million USD | 0.859% |
| Actinium Pharmaceuticals, Inc. | 81 Thousand USD | -5443.321% |
| Azitra, Inc. | 686 Thousand USD | -554.532% |
| Can-Fite BioPharma Ltd. | 743 Thousand USD | -504.319% |
| Chromocell Therapeutics Corporation | - USD | -Infinity% |
| Calidi Biotherapeutics, Inc. | - USD | -Infinity% |
| CEL-SCI Corporation | - USD | -Infinity% |
| iBio, Inc. | 225 Thousand USD | -1895.596% |
| Lineage Cell Therapeutics, Inc. | 8.94 Million USD | 49.803% |
| MAIA Biotechnology, Inc. | - USD | -Infinity% |
| Matinas BioPharma Holdings, Inc. | 1.09 Million USD | -309.68% |
| Navidea Biopharmaceuticals, Inc. | 65.65 Thousand USD | -6739.228% |
| NovaBay Pharmaceuticals, Inc. | 14.72 Million USD | 69.509% |
| NanoViricides, Inc. | - USD | -Infinity% |
| Oragenics, Inc. | 37.65 Thousand USD | -11824.92% |
| BiomX Inc. | -357 Thousand USD | 1357.728% |
| BiomX Inc. | -357 Thousand USD | 1357.728% |
| Protalix BioTherapeutics, Inc. | 65.49 Million USD | 93.144% |
| Scorpius Holdings, Inc. | 6.99 Million USD | 35.809% |